The objective of the Fund is to provide long-term capital growth with a reasonable and growing level of income.
Name | % Net Assets |
---|---|
Vodafone Group PLC | 5.8% |
BG Group PLC | 4.8% |
AstraZeneca PLC | 4.1% |
Royal Dutch Shell PLC | 3.9% |
Imperial Tobacco Group PLC | 3.7% |
BT Group PLC | 3.6% |
Unilever PLC | 3.4% |
British American Tobacco PLC | 3.2% |
Wolseley PLC | 2.8% |
National Grid PLC | 2.8% |
Key | % Net Assets |
---|---|
Vodafone Group PLC | 5.8% |
BG Group PLC | 4.8% |
AstraZeneca PLC | 4.1% |
Royal Dutch Shell PLC | 3.9% |
Other | 81.4% |
Date | 21-Nov-2024 |
---|---|
NAV | 97.00p |
Currency | GBP |
Change | -0.070p |
% | -0.07% |
YTD change | 2.49p |
YTD % | 2.63% |
Fund Inception | 28/11/1966 |
---|---|
Fund Manager | Chris White |
TER | 1.62 (30-Mar-2012) |
Minimum Investment | |
---|---|
Initial | £500000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.07 |
You are here: research